Surgical Reconstruction (Flaps, Grafts)
Treatment for Decubitus ulcer
Typical Dosage: Surgical procedure
Effectiveness
75%
Safety Score
50%
Clinical Trials
80
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
50
DangerousModerateSafe
Treatment Details
Dosage Range
Surgical procedure
Time to Effect
Immediate closure, long recovery (weeks-months)
Treatment Duration
One-time surgery with extensive post-operative care (weeks to months)
Evidence Quality
MODERATENumber Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,000
Side Effect Mgmt:$2,000
Total Annual:$60,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$75,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$70,588.24
Cost per Remission
$85,714.29
Surgical Reconstruction (Flaps, Grafts) Outcomes
for Decubitus ulcer
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+85%
Remission Rate
+70%
Common Side Effects
Flap failure/necrosis
+10%
Wound infection
+8%
Bleeding/hematoma
+7%
Recurrence of ulcer
+30%
Anesthesia risks
+5%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov